MarketCap
Facebook
X
Telegram
Country |
 USA |
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
136 M |
Market Cap[1] |
$ 8.21 B |
EBITDA (LTM) |
$ -907 M |
P/E (LTM) |
-10.863233 |
P/S (LTM) |
- |
EPS (LTM) |
-5.63 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Фармсинтез
LIFE
|
- | - | - | MOEX |  Russia |
 |
Ayala Pharmaceuticals
AYLA
|
- | - | $ 7.46 M | Nasdaq Global Market |  Israel |
 |
Amryt Pharma plc
AMYT
|
- | - | $ 621 M | Nasdaq Global Select Market |  Britain |
 |
ASLAN Pharmaceuticals Limited
ASLN
|
- | -14.27 % | $ 1.7 M | Nasdaq Global Market |  Singapore |
 |
Revolution Medicines
RVMD
|
$ 207.32 | 0.24 % | $ 39.4 B | Nasdaq Global Select Market | USA |
 |
Rhythm Pharmaceuticals
RYTM
|
$ 101.8 | 0.08 % | $ 6.62 B | Nasdaq Global Market,SPB | USA |
|
Rezolute
RZLT
|
$ 4.4 | 0.88 % | $ 334 M | Nasdaq Capital Market | USA |
 |
Sana Biotechnology
SANA
|
$ 3.45 | 0.77 % | $ 874 M | Nasdaq Global Select Market | USA |
 |
Seer
SEER
|
$ 1.95 | 0.26 % | $ 108 M | Nasdaq Global Select Market | USA |
 |
Precigen
PGEN
|
$ 6.87 | 0.14 % | $ 2.15 B | Nasdaq Global Select Market | USA |
 |
SIGA Technologies
SIGA
|
$ 3.2 | 1.86 % | $ 229 M | Nasdaq Global Select Market | USA |
 |
Syndax Pharmaceuticals
SNDX
|
$ 19.94 | 0.05 % | $ 1.73 B | Nasdaq Global Select Market | USA |
 |
Soligenix
SNGX
|
$ 0.38 | 1.18 % | $ 1.97 M | Nasdaq Capital Market | USA |
 |
Spruce Biosciences
SPRB
|
$ 59.09 | 2.0 % | $ 45.3 M | Nasdaq Global Select Market | USA |
 |
Sarepta Therapeutics
SRPT
|
$ 20.94 | 0.04 % | $ 2.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Stoke Therapeutics
STOK
|
$ 30.05 | 0.81 % | $ 1.78 B | Nasdaq Global Select Market,SPB | USA |
 |
Sutro Biopharma
STRO
|
$ 19.1 | 0.34 % | $ 162 M | Nasdaq Global Select Market | USA |
 |
Shattuck Labs
STTK
|
$ 6.5 | 0.29 % | $ 452 M | Nasdaq Global Select Market | USA |
 |
Supernus Pharmaceuticals
SUPN
|
$ 42.43 | 0.23 % | $ 2.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Savara
SVRA
|
$ 5.53 | 2.98 % | $ 1.23 B | Nasdaq Global Select Market | USA |
 |
China SXT Pharmaceuticals
SXTC
|
$ 2.24 | 0.45 % | $ 1.52 M | Nasdaq Global Select Market |  China |
 |
Takeda Pharmaceutical Company Limited
TAK
|
$ 18.32 | 1.49 % | $ 28.9 B | NYSE |  Japan |
 |
Bio-Techne Corporation
TECH
|
$ 72.31 | 0.01 % | $ 11.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Tenax Therapeutics
TENX
|
$ 1.98 | 2.06 % | $ 77.7 M | Nasdaq Global Select Market | USA |
 |
Teva Pharmaceutical Industries Limited
TEVA
|
$ 36.76 | 1.21 % | $ 42.1 B | NYSE | Israel |
 |
TG Therapeutics
TGTX
|
$ 55.74 | 0.58 % | $ 8.04 B | Nasdaq Capital Market | USA |
 |
Trevi Therapeutics
TRVI
|
$ 16.82 | 1.17 % | $ 2.27 B | Nasdaq Global Market | USA |
 |
Taysha Gene Therapies
TSHA
|
$ 5.48 | 0.54 % | $ 1.75 B | Nasdaq Global Select Market | USA |
 |
Sol-Gel Technologies Ltd.
SLGL
|
$ 69.37 | 0.35 % | $ 193 M | Nasdaq Global Select Market | Israel |
 |
UroGen Pharma Ltd.
URGN
|
$ 43.82 | 0.02 % | $ 2.11 B | Nasdaq Global Select Market | Israel |
 |
United Therapeutics Corporation
UTHR
|
$ 497.97 | 2.12 % | $ 22.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Spero Therapeutics
SPRO
|
$ 1.19 | 0.41 % | $ 66.7 M | Nasdaq Global Select Market | USA |
 |
Scholar Rock Holding Corporation
SRRK
|
$ 57.42 | 3.78 % | $ 6.59 B | Nasdaq Global Select Market | USA |
 |
Jounce Therapeutics
JNCE
|
- | - | $ 98.4 M | Nasdaq Global Select Market | USA |
 |
NextCure
NXTC
|
$ 8.42 | 7.67 % | $ 23.9 M | Nasdaq Global Select Market | USA |
 |
Verrica Pharmaceuticals
VRCA
|
$ 5.26 | 0.75 % | $ 56 M | Nasdaq Global Market | USA |
 |
Viridian Therapeutics
VRDN
|
$ 23.17 | 1.09 % | $ 2.36 B | Nasdaq Capital Market | USA |
 |
Zosano Pharma Corporation
ZSAN
|
- | 7.23 % | $ 2.72 M | Nasdaq Global Select Market | USA |
 |
Vertex Pharmaceuticals Incorporated
VRTX
|
$ 528.9 | 0.22 % | $ 135 B | Nasdaq Global Select Market,SPB | USA |
 |
Verastem
VSTM
|
$ 8.08 | 0.55 % | $ 560 M | Nasdaq Global Market | USA |
 |
vTv Therapeutics
VTVT
|
$ 32.79 | 0.03 % | $ 130 M | Nasdaq Global Select Market | USA |
 |
Voyager Therapeutics
VYGR
|
$ 3.4 | 3.85 % | $ 200 M | Nasdaq Global Select Market | USA |
 |
Aravive
ARAV
|
- | -13.39 % | $ 1.45 M | Nasdaq Global Select Market | USA |
 |
Wave Life Sciences Ltd.
WVE
|
$ 4.91 | 1.03 % | $ 828 M | Nasdaq Global Select Market | Singapore |
 |
Tonix Pharmaceuticals Holding Corp.
TNXP
|
$ 13.16 | 0.15 % | $ 112 M | Nasdaq Global Select Market | USA |
 |
Xenetic Biosciences
XBIO
|
$ 4.28 | 0.86 % | $ 7.28 M | Nasdaq Capital Market | USA |
|
XBiotech
XBIT
|
$ 2.18 | 0.23 % | $ 66.5 M | Nasdaq Global Select Market | USA |
 |
Exicure
XCUR
|
$ 1.41 | 12.8 % | $ 8.88 M | Nasdaq Capital Market | USA |
 |
Xenon Pharmaceuticals
XENE
|
$ 59.55 | 0.18 % | $ 4.72 B | Nasdaq Global Select Market |  Canada |
 |
Xeris Pharmaceuticals
XERS
|
$ 8.48 | 0.12 % | $ 1.36 B | Nasdaq Global Select Market | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.